RNAC Cartesian Therapeutics, Inc.
$8.19▼ -2.85%
Healthcare
Other
After hours
$8.19▲ +0.00%
Sep 11, 7:30 PM ET
Volume 123.1K
Avg Volume (10D) 94.6K
Key Metrics & Fundamentals
Market Cap
$247.79M
P/E Ratio
–
Div Yield
–%
52W Range
5.60 - 11.00
% vs 50 MA
-8.31%
% vs 200 MA
6.30%
RSI-14
35.6
MACD Histogram
-0.2000
Beta (1Y vs SPY)
1.65
Free Cash Flow
-$21.35M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$27.15M
COGS
–
Operating Exp
$29.16M
Operating Income
-$29.16M
EBIT
-$29.16M
Pretax Income
$15.77M
Net Income
$15.77M
EPS (Diluted)
0.46
Price & Volume History
Loading chart…
Recent News
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire · Sep 8, 2026 11:00 AM
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 11:00 AM
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 6, 2026 11:00 AM
Kyverna Therapeutics Sinks 13%: Here’s Why
24/7 Wall St. · Jul 10, 2026 7:59 PM
New Strong Sell Stocks for July 1st
Zacks · Jul 1, 2026 7:33 AM
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?
Zacks · Jun 30, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See RNAC's money flow as a full page
Social Sentiment
No Reddit posts found for RNAC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.